COMPACT MEDICAL INC.

COMPACT MEDICAL INC. specializes in the design, development, and manufacturing of medical devices and related healthcare technologies, operating under NAICS 339112, which encompasses surgical and medical instrument manufacturing. The company’s core capabilities center on precision engineering of disposable and reusable medical devices, with technical expertise in materials science, biocompatible component fabrication, and regulatory-compliant production processes aligned with FDA Quality System Regulation and ISO 13485 standards. While specific award details are not available, their operational focus suggests deep proficiency in low-volume, high-integrity manufacturing for clinical environments, including assembly of diagnostic tools, procedural instruments, and patient-care devices requiring stringent sterility and performance controls. Differentiators likely include controlled-environment manufacturing protocols, traceability systems for lot-specific documentation, and experience navigating the complexities of Class I and II medical device development. No agency relationships can be inferred due to absence of award data, and no recent contract history is available to characterize customer engagement patterns. The company’s industry focus is narrowly defined by NAICS 339112, positioning it within the medical device manufacturing sector with an emphasis on surgical, diagnostic, and therapeutic instrumentation. This vertical requires adherence to rigorous design controls, risk management frameworks, and post-market surveillance requirements, indicating a market positioning as a specialized supplier to OEMs, hospitals, or government health systems requiring certified, non-implantable medical tools. COMPACT MEDICAL INC. is structured as a small business under the 2L entity classification, with its primary operations based in Indianapolis, Indiana. The company holds no federal certifications such as 8(a), HUBZone, or WOSB, and there is no public record of ISO or FDA registrations in the provided data. Its government market presence appears limited to direct procurement channels without visible subcontracting or teaming relationships, suggesting a focused, niche supplier role within the broader healthcare infrastructure.